The PAAB logo provides assurance that the information you receive has undergone independent review. During our preclearance review, we verify that patient material is not promotional and that it is consistent with Health Canada approved product information and is based on authoritative sources for disease information.
Your perspective is important to us. Get involved in shaping the standards that are applicable to patient information materials generated by the pharmaceutical industry. Simply express your interest to participate on future PAAB advisory committees in an email to email@example.com.
Healthcare product manufacturers are required to ensure that the PAAB logo appears on all materials approved by PAAB (whether print or digital). The presence of this logo indicates that the material has undergone a PAAB review to verify that the content is:
You rely on your healthcare professionals to be informed as their judgements have profound implications on your well-being. PAAB ensures that advertising for medications, natural health products, and homeopathic products that is directed to healthcare professionals does not misinform them. The PAAB code requires that healthcare professional advertising be:
PAAB also provides an advisory opinion on materials that are distributed or visible to the general public. The Health Canada policy document “The Distinction Between Advertising and Other Activities", is used as the basis for PAAB’s assessment.
Consumer Ad Campaigns
Brand Reminder ads
Clinical Trial Recruitment
Are you a representative from a patient association? Contact us at firstname.lastname@example.org if you’d like PAAB to come visit your association to perform a presentation about what we do, why we do it, and when patient materials created through collaboration between the association and the pharmaceutical industry require PAAB review.
View our resources on our website which are particularly relevant to you. For example, did you know that some patient information materials created through collaboration between the pharmaceutical industry and patient associations require PAAB review?